Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Exactly, they value potential companies on many as aspects, some of which are future revenues and ROI. If a potential buyer thought there was a decent chance for ADXS to have significant revenues in the future, then buying the company for 5-10SP would be a great deal for them. The fact that nothing what so ever regarding a potential BO has ever occurred here, means BP does not see this as a good ROI even down here in the 2’s.

It’s as simple as that really. ADXS is still a lottery ticket that could pay off huge for a buyer one day, or they could take a wash on the deal. With markets at all-time highs and ADXS at all-time lows, it would seem that talks of a hypothetical BO should be the last thing this MB should be concerned with.